Pediatric nuclear medicine dosimetry addresses the unique radiological and pharmacological considerations required when imaging and treating children. This discipline combines precise radiation accounting with age-specific pharmacokinetics to ensure that diagnostic and therapeutic procedures remain as safe and effective as possible for young patients.
Because children have ongoing tissue development, different organ radiosensitivity, and varied body proportions, standard adult dosimetry methods cannot be applied directly. The following sections outline core concepts, practical workflows, and emerging data relevant to optimizing dose in the pediatric population.
| Patient Category | Key Physiological Factors | Implication for Dosimetry | Recommended Approach |
|---|---|---|---|
| Infant (0–1 year) | High surface-area-to-mass ratio, rapidly dividing tissues | Higher relative organ dose for administered activity | Weight- and age-adjusted dosing, use of neonate pharmacokinetic models |
| Child (1–12 years) | Organ size changes, variable body composition | Dose estimates may shift with growth milestones | Age-band modules, updated pediatric MIRD tables |
| Adolescent (13–18 years) | 接近成人体重与解剖变异接近成人体重与解剖变异 | 可使用成人参考剂量，但仍需个体化评估 | 逐步过渡到成人协议，强化知情同意与剂量记录 |
Developmental Physiology in Pediatric Dosimetry
Organ Maturity and Tissue Sensitivity
During early childhood, organs such as the thyroid, bone marrow, and gonads exhibit heightened radiosensitivity and ongoing developmental changes. These factors influence both the magnitude of absorbed dose and the potential for late stochastic effects, requiring age-specific dosimetry models rather than direct extrapolation from adult data.
Growth Kinetics and Radionuclide Kinetics
Changes in body water content, fat mass, and organ size alter the volume of distribution and retention time of radiopharmaceuticals. Pediatric dosimetry must incorporate longitudinal growth patterns to accurately model biodistribution and clearance, especially for therapies with narrow therapeutic indices.
Dose Assessment Methods and Clinical Workflow
Internal Dosimetry Using Pediatric MIRD
Standardized methods such as the pediatric MIRD formalism enable calculation of absorbed dose to target and critical organs. S-factors and biokinetic models tailored to children support more reliable risk estimates for both diagnostic and therapeutic applications.
Imaging-Based and Patient-Specific Modeling
Modern workflows integrate planar and SPECT/CT imaging with Monte Carlo or analytical approaches to derive personalized dose distributions. These methods account for anatomical heterogeneity and motion, improving accuracy compared to simplified phantom-based estimates.
Optimization Strategies and Safety Considerations
Protocol Customization and Activity Adjustment
Adjusting administered activity based on weight, age, and clinical indication reduces unnecessary exposure while maintaining diagnostic or therapeutic efficacy. Institutional guidelines and checklists help ensure consistent implementation across diverse pediatric cases.
Quality Assurance and Long-Term Follow-Up
Routine calibration, participation in pediatric network audits, and systematic dose recording support continuous improvement. Longitudinal follow-up programs enable the assessment of late effects and refinement of dose thresholds for specific pathologies.
Clinical Implementation and Future Directions
Adopting a structured, data-driven approach to pediatric nuclear medicine dosimetry enhances patient safety and supports personalized medicine. Continuous integration of new radiopharmaceuticals, updated reference values, and advanced computational tools will further optimize risk–benefit profiles across all age groups.
- Apply age- and weight-specific activity scaling protocols for every pediatric study or therapy
- Use pediatric MIRD and imaging-based dosimetry to refine organ dose estimates
- Implement routine quality assurance and calibration checks tailored to pediatric equipment
- Establish longitudinal follow-up to monitor potential late effects and refine dose thresholds
- Engage in multicenter audits and guideline updates to align with evolving best practices
FAQ
Reader questions
How should administered activity be adjusted for infants compared to older children?
Infants require weight- and age-based scaling of administered activity, often using neonate-specific biodistribution models, to avoid overestimation of target dose and underestimation of organ dose.
What role do pediatric MIRD tables play in therapeutic dosimetry?
Pediatric MIRD tables provide age- and size-appropriate S-factors and biokinetic parameters, enabling more accurate absorbed dose estimates for radioligand therapy in children and adolescents.
Can imaging-based dosimetry replace standard MIRD calculations in children?
Imaging-based approaches complement standard MIRD by capturing individual anatomical and physiological variability, improving dose accuracy especially in complex cases or rapidly growing patients.
What are the key quality assurance metrics for pediatric nuclear medicine dosimetry?
Key metrics include equipment calibration records, activity measurement traceability, protocol adherence audits, and participation in external quality assessment programs focused on pediatric imaging and therapy.